Navigation Links
Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
Date:4/17/2013

SAN DIEGO, April 17, 2013 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that two posters for its lead product candidate, MST-188, were presented at the 7th Annual Sickle Cell Disease Research & Educational Symposium, currently underway in Miami.  

Brian M. Culley , Chief Executive Officer, said: "Increasing evidence suggests that transfusion of 'older' red blood cells (RBC) impairs clinical outcomes as a result of defects resulting from storage or age.  An NIH meta-analysis of 21 studies involving more than 400,000 patients reported that transfusion of older versus newer blood was associated with significantly increased risk of death.  Since older RBC aggregate more than younger RBC, we hypothesize that increased RBC aggregation following transfusion of older RBC or those with 'storage lesion' impairs blood flow in the microcirculation, where the majority of oxygen and nutrient exchange occur, thereby decreasing tissue perfusion and worsening outcomes." 

Mr. Culley continued: "The data presented today show that MST-188 reduced aggregation of both older and younger RBC, with a greater effect on older RBC.  If adverse clinical outcomes following transfusion are the result of increased RBC aggregation in the microcirculation, MST-188 may offer an option to improve the efficacy of transfusion.  We are conducting additional preclinical studies in this area, with the goal of helping to improve treatment options for the 4.5 million people who, in the U.S. alone, receive a transfusion each year." 

Poster Information:

  • The poster entitled "Is There a Role for a Rheologic Agent in Transfusion?" was presented by R. Martin Emanuele , Ph.D., Senior Vice President, Development
  • The poster entitled "Ev
    '/>"/>

SOURCE Mast Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
2. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
3. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
4. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
5. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
6. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
7. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
8. Halozyme Therapeutics Names Matt Posard to Board of Directors
9. Mast Therapeutics Engages ESC Advisors To Identify Partnering Opportunities For MST-188
10. Cell Therapeutics Secures $15 Million Loan Financing Agreement
11. United Therapeutics Announces Receipt Of Second Complete Response Letter For Oral Treprostinil NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... N.J. , July 24, 2014 IGI ... Jersey based specialty generic pharmaceutical company, today ... from its Board of Directors.  Mr. Finio has accepted ... and under the terms of his acceptance of his ... in his role as Director for IGI Laboratories, Inc.  ...
(Date:7/24/2014)... , July 24, 2014 LSI ... signed an Agreement with Kineticos, a ... company. Kineticos will support LSI Medience in identifying ... management, to demonstrate utility in clinical trials. ... potential utility in diagnosis of sepsis, prognosis of ...
(Date:7/24/2014)... Calif. , July 24, 2014  Lazarus ... development of novel interventional devices to facilitate removal ... States Patent and Trademark Office has issued a ... technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever (stentriever) ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2
... -- ADVANCE FOR RELEASE AT 5 P.M. EST MONDAY, ... Patients,who undergo complete prostate removal are less likely to ... done by an,experienced surgeon in a hospital that does ... the Agency for Healthcare Research and,Quality, part of the ...
... Regions of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, ... placebo-controlled trials showed patients with moderate,to severe plaque psoriasis receiving ... each of the four body regions,(head, trunk, lower and upper ...
Cached Medicine Technology:Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 2Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 3Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10
(Date:7/24/2014)... July 25, 2014 Voted one of ... the global clients, BellasDress focuses on providing its new ... fashion information. Recently, the company has announced its new ... the new range is created according to the latest ... discounts, up to 68% off. , As a matter ...
(Date:7/24/2014)... 2014 The report, “Content Delivery ... market into various sub-segments with an in-depth analysis ... drivers and restraints for this market with insights ... market data tables and 36 figures spread through ... Networks (CDN) Market” at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . ...
(Date:7/24/2014)... Just as fitness and health professionals ... own financial and marketing strength to be important as ... the next level by using the most powerful communication ... Broadcast, Call Tracking and SMS texting solutions . ... messages are quickly become integral in marketing and communication ...
(Date:7/24/2014)... its 2014 Power of A Award winners, including two ... , The ASA Global Humanitarian Outreach (GHO) program ... the top honors from ASAE. GHO was honored for ... on the global anesthesia crisis and supporting low income ... honored with a Power of A Silver Award for ...
(Date:7/24/2014)... appears to increase the risk for head and neck cancer ... with DM, but the risk of HNC in patients with ... cancer is the sixth most common type of cancer. It ... an estimated 650,000 new cancer cases and 350,000 cancer deaths ... Insurance Research Database to examine the risk of HNC in ...
Breaking Medicine News(10 mins):Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3
... sites nationwide, - Triples network bandwidth to more than 1 Gbps at ... ... solution, ROCHESTER, N.Y., March 18 Time Warner Telecom,Inc. (Nasdaq: ... businesses, today announced a multi-year, contract,to deploy an eight-site IP VPN solution ...
... PartsSource, the nation,s,leading supplier of replacement medical repair ... Team NEO award. Team NEO recognizes,the exceptional companies ... as the engines fueling the Cleveland area economy., ... what,s right about Northern Ohio,business," said President & ...
... Using data from the SCIAMACHY instrument aboard ESA,s Envisat ... regionally elevated atmospheric carbon dioxide the most important ... from manmade emissions. , More than 30 billion tonnes ... into the atmosphere annually by human activities, mainly through ...
... New U of T research holds promise for ... serve as a model for future therapies against the ... Stagljar, University of Toronto scientists have identified several compounds ... ExoS). One of these compounds, exosin, significantly inhibited infections ...
... March 18 On The Go,Healthcare, Inc. (OTC ... computer hardware, software and systems integrator,announced today that ... the Company has sold its Value Added Reseller ... (OTC Bulletin Board: FLIP). The,terms of the sale, ...
... or not relatives talk about the familys history of ... and testing for those at moderate risk of developing ... today at the American Society for Preventive Oncology meeting ... African Americans participate less often in genetic counseling and ...
Cached Medicine News:Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 2Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 3Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 3Health News:Research promising for cystic fibrosis 2Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 2Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 3Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 4Health News:Family communication impacts attitude about genetic counseling/testing for breast cancer 2
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures....
... Webster is the source for a complete ... catheters for left-sided mapping - all with ... come to expect from the leader in ... sinus diagnostic catheters are specifically designed and ...
... Inquiry 5FR Soft HIS diagnostic ... a uniquely designed curve that ... in the HIS bundle. In ... designed to reduce the risk ...
Standard Deflectable Catheters...
Medicine Products: